Glenmark takes Napo to arbitration over crofelemer
Napo Pharmaceuticals Inc, the innovator company behind anti-diarrhoea drug crofelemer, is finding itself in litigation with its partners. The company owns crofelemer, a novel anti-diarrhoeal drug under development, which is in advanced stages in the clinial trial process and is widely anicipated to hit the market.
Continue Reading